The consequences of 2020 Coronavirus have been so dramatic that it shattered the economy of 150 countries – jeopardizing their lifestyle, economy, impacting business and assumption of common wellbeing which we had taken for granted. It has thrown the whole world into a global recession.
The nationwide coronavirus vaccination drive began with two approved vaccinations of Serum Institute of India’s Covishield- developed by Oxford -AstraZeneca and Bharat Biotech’s Covaxin. The Covishield is approved for restricted use in emergency situation vaccine that may prevent COVID-19 disease in individuals 18 years of age and older. While, Covaxin is India’s indigenous COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
Why Covaxin is coming with a consent form?
Bharat Biotech’s COVID-19 vaccine Covaxin was granted restricted emergency use approval under clinical trial mode. This meant that people who received the vaccine would have to sign a three-page informed consent form, and would also be monitored for any serious side effects.
“In case of any adverse events or serious adverse events, you will be provided a medically recognized standard of care in government-designated authorized centers or hospitals,” the consent form said.
The form also states that in case of any serious adverse side-effects, Bharat Biotech will pay the compensation, if it is proved that event occurred due to the vaccine.
The recipients are also handed a factsheet in which they are asked nine questions, including:
Free for members
Keep reading — it's free
The rest of this article is open to DentalReach members. Create a free account, or sign in, and every article on the site opens in full.